Delivery Order SPE2DB22D2009-SPE2DB24FL8RF
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,034.53, is for the supply of 4,568,060,823 units of the drug Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 90 tablets of the prescription medication Valsartan-HCTZ 160-12.5 mg, with a potential value of $8,219.58 and a completion date of February 21, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order. No set-aside designation...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit organization, for the supply of Valsartan-HCTZ 320-25 mg tablets. The award has a ceiling value of $3,680.91 and a performance period through March 25, 2024. AmerisourceBergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages, with a potential value of $1,333.74 and a completion date of February 6, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packaging, with a completion date of February 14, 2024 and a potential value of $2,140.15. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,578.30, is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets in 90-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Valsartan-HCTZ 160-12.5 mg tablets. The contract has a ceiling value of $1,474.89 and a period of performance through April 10, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $4,450.69, is for the delivery of 4,563,926,962 units of the pharmaceutical product Valsartan-HCTZ 320-25 mg Tablets, with a period of performance through March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles. The $6,429.84 firm-fixed-price contract has a completion date of February 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a for-profit pharmaceutical distribution company, to provide 90 tablets of the prescription medication Valsartan-HCTZ 160-12.5 mg. The $2,292.30 delivery order has a completion date of February 2, 2024. Amerisourcebergen Drug Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL8RFDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $12,738.48 contract provides for the delivery of Valsartan-HCTZ 320-25 mg tablets over a period ending on March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation mentioned. The company holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for providing pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 3/12/24 |